Sudeep Pharma IPO GMP Hints At Listing With Over 20% Gains - Check Details

Sudeep Pharma IPO Subscription: The initial public offering of Sudeep Pharma Ltd opened on November 21. The pharmaceutical company’s public issue is garnering decent investor interest on the second day of subscription.

Sudeep Pharma IPO has been booked over 3 times on the second day of subscription. The grey market premium (GMP) of the pharmaceutical company’s shares also remained steady, hinting at a decent listing for the stock.

Sudeep Pharma IPO Subscription

Sudeep Pharma IPO has received bids for over 37.3 million shares so far against the 10.5 million shares offered for subscription, leading to the issue being booked 3.53 times.

Non-institutional investors (NIIs) are leading the demand for Sudeep Pharma’s shares as the issue has been booked 7.72 times in the NII category so far. NII’s have placed bids for 17.4 million shares of the company against the 2.26 million shares reserved for the category.

Sudeep Pharma IPO has been booked 3.69 times by retail individual investors (RIIs) so far. RIIs placed bids for 19.48 million shares compared to the 5.28 million shares set aside for retail investors.

Qualified institutional buyers (QIBs) have applied for 3,34,500 shares of the software company’s public issue so far on the second-last day of bidding against the 3.01 million shares reserved for the category, booking the issue 11 per cent.

Sudeep Pharma IPO GMP

Sudeep Pharma IPO grey market premium (GMP) held steady on the second day of subscription. The grey market premium of Sudeep Pharma’s shares remained around Rs 112 per share as per several websites which monitor the demand for shares of unlisted companies. Sudeep Pharma shares are expected to list with gains of 18.89 per cent at Rs 705 per share.

Sudeep Pharma IPO Issue Size

Sudeep Pharma Ltd seeks to raise Rs 895 crore from its public issue. The pharmaceutical company’s public offer consists of a fresh issue of 1.6 million shares amounting to Rs 95 crore and an offer-for-sale of 13.5 million shares.

Sudeep Pharma IPO Price Band

Sudeep Pharma IPO price band was set at Rs 563 to Rs 593 per share. The minimum lot size for retail individual investors was fixed at 25 shares, which aggregates to an investment of Rs 14,825.

Sudeep Pharma IPO: Subscription Dates and Listing Date

Sudeep Pharma IPO subscription window is scheduled to close on November 25. The share allotment status of Sudeep Pharma IPO will be announced on November 26. Subsequently, Sudeep Pharma Ltd will issue refunds for unsuccessful applicants on November 27. Sudeep Pharma Ltd shares are scheduled to list on the bourses on November 28.

Sudeep Pharma: Financials

Sudeep Pharma posted a total income of Rs 130.08 crore in the June quarter of FY26. In the quarter under review, the software firm’s net profit and net worth stood at Rs 31.27 crore and Rs 688.32 crore, respectively.

In FY25, the company posted a total income of Rs 511.33, increasing by nearly 10 per cent from Rs 465.38 crore in the preceding fiscal. The excipient maker’s net profit for FY25 stood at Rs  138.69 crore, growing by over 4 per cent from Rs 133.15 crore in the preceding fiscal. The net worth of the pharma company surged by more than 38 per cent to Rs 497.53 crore in FY25 compared to Rs 359.07 crore in FY24.

Sudeep Pharma IPO: Registrar

Sudeep Pharma IPO’s book running lead manager is ICICI Securities Ltd, and the registrar for the issue is MUFG Intime India Pvt.Ltd.

Sudeep Pharma: Promoters

The promoters of Sudeep Pharma Ltd include Sujit Jaysukh Bhayani, Avani Sujit Bhayani, Shanil Sujit Bhayani, Sujeet Jaysukh Bhayani HUF, Riva Resources Private Ltd, and Bhayani Family Trust. Promoters of the company held 89.37 per cent stake in the company prior to the issue. The shareholding of the promoters will reduce to 76.15 per cent after the listing of the shares.

Sudeep Pharma IPO: Objective

The pharmaceutical company plans to use the proceeds of the public issue for the procurement of machinery for its production line at the Nandesari Facility. Sudeep Pharma will also use the proceeds of the public issue for general corporate purposes.

About Sudeep Pharma

Sudeep Pharma Ltd was incorporated in 1989. The company is engaged in the manufacturing of pharmaceutical excipients, food-grade minerals, and speciality nutrition ingredients. The pharmaceutical company has six facilities and supplies over 200 products to the pharma, food, and nutrition industries.